Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
National Eye Institute (5R01EY015534, R21EY026229)
Oklahoma Center for the Advancement of Science and Technology (HR12-068)
National Institute of General Medical Sciences (U54GM104938)
- License Information
-
More Information
Article History
Received: 26 February 2018
Accepted: 16 August 2018
First Online: 27 August 2018
Ethics approval and consent to participate
: All studies performed by our laboratory involving human brain tissues were exempt from review by the Institutional Review Board.
: Not applicable
: Author AJS has declared that no competing interests exist. Author AKJ has received funding from the Oklahoma Center for Advancement of Science and Technology and National Eye Institute. Author HAP has declared equity in Biolytx Pharmaceuticals Corp and funding obtained through the National Eye Institute, National Institute of General Medical Sciences, and the Oklahoma Center for the Advancement of Science and Technology for support of this study.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
